Skip to main content
SpringerLink
Log in

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The aim of this study was to evaluate the usefulness of salmon calcitonin (sCT) in preventing corticosteroid-induced osteoporosis. Three groups of patients with sarcoidosis requiring long-term steroid therapy were followed for 2 years with yearly evaluations of vertebral cancellous mineral content (VCMC) by quantitative computed tomography. The first group (n=18) was treated with intramuscular (i.m.) sCT for the 2-year study period; the second (n=11) with i.m. sCT for the first 4 months and then with sCT nasal spray for 20 months; the third (n=35) received no sCT. We observed a large mineral loss in the third group but a very slight drop of VCMC in the two groups receiving sCT. SCT nasal spray was better tolerated and as effective as i.m. injections. The action of sCT appeared extremely useful, especially in the first year of steroid therapy when corticosteroid-induced mineral loss was maximal. We conclude that sCT nasal spray is a good tool for preventing corticosteroid-induced osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bressot C, Meunier PG, Chapuy MC, Lejeune E, Eduoard C, Darby AJ (1979) Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1:303–319

    Article  Google Scholar 

  2. Dempster DW, Arlot MA, Meunier PJ (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35:410–417

    Article  PubMed  CAS  Google Scholar 

  3. Frost HM, Villanueva AR (1961) The effect of cortisone on lamellar osteoblastic activity. Henry Ford Hosp Med J 9:97–99

    PubMed  CAS  Google Scholar 

  4. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352–364

    PubMed  CAS  Google Scholar 

  5. Hahn TJ (1978) Corticosteroid-induced osteopenia. Arch Intern Med 138:882–885

    PubMed  Google Scholar 

  6. Reid IR (1989) Steroid osteoporosis. Calcif Tissue Int 45:63–67

    Article  PubMed  CAS  Google Scholar 

  7. Suzuki Y, Ichikawa Y, Saito E, Homma M (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151–156

    Article  PubMed  CAS  Google Scholar 

  8. Reid IR, Ibbertson HK (1987) Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Hormone Res 27:200–204

    Article  PubMed  CAS  Google Scholar 

  9. Delorne AC, Danan JL, Mathieu H (1983) Biochemical evidence for the presence of two vitamin D-dependent calcium-binding proteins in mouse kidney. J Biol Chem 258:1878–1884

    Google Scholar 

  10. Fucik RF, Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Williams GA (1975) Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 40:152–155

    Article  PubMed  CAS  Google Scholar 

  11. Riggs BL (1988) Practical management of the patient with osteoporosis. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York, 481–490

    Google Scholar 

  12. Chen TL, Cone CM, Morey-Holton E, Feldman D (1982) Glucocorticoid regulation 1-25(OH)2 vitamin D3 receptors in cultured mouse bone cells. J Biol Chem 257:13564–13569

    PubMed  CAS  Google Scholar 

  13. Chen TL, Cone CM, Morey-Holton E, Feldman D (1983) 1 α 25 dihydroxyvitamin D3 receptors in cultured rat osteoblast-like cells. Glucocorticoid treatment increased receptor content. J Biol Chem 258:4350–4355

    PubMed  CAS  Google Scholar 

  14. Nielsen HK, Eriksen EF, Storm T, Mosekilde L (1988) The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjects. Metabolism 37:109–114

    Article  PubMed  CAS  Google Scholar 

  15. Azria M (1989) Endogenous calcitonin. In: Azria M (ed) The calcitonins: physiology and pharmacology. Karger, Basel, p 48

    Google Scholar 

  16. Chesnut CH, Baylink DJ, Gruber HE, Ivey JL, Matthews M, Nelp WB, Sisom K, Taggart HM, Reynolds JC, Roos BA (1984) Synthetic salmon calcitonin in postmenopausal osteoporosis: current concepts. In: Avioli LV, Dambacher MA (eds) Calcitonin: Das therapeutische Potential bei osteoporose. Scharrauer, Stuttgart, New York

    Google Scholar 

  17. Locascio VL, Adami S, Avioli LV, Comicacini L, Galvanini G, Gennari C, Imbimbo B, Scuro LA (1982) Suppressive effect of chronic corticoid treatment on circulating calcitonin in man. Calcif Tissue Int 34:309–311

    Article  PubMed  CAS  Google Scholar 

  18. Rizzato G, Tosi G, Schiraldi G, Montemurro L, Zanni D, Sisti S (1988) Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. Sarcoidosts 5:99–103

    CAS  Google Scholar 

  19. Rizzato G, Schiraldi G, Tosi G, Locicero S, Montemurro L, Zanni D, Sisti S (1989) Administration of salmon calcitonin nasal spray for long-term treatment of corticosteroid-induced osteoporosis. A preliminary report. Curr Ther Res 45:761–766

    Google Scholar 

  20. Rizzato G, Tosi G, Mella C, Montemurro L, Zanni D, Sisti S (1988) Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women. Sarcoidosis 5:93–98

    PubMed  CAS  Google Scholar 

  21. Cann CE, Genant HK (1983) Single versus dual energy CT for vertebral mineral quantification. J Comput Assit Tomogr 7:551–560

    Article  Google Scholar 

  22. Montemurro L, Fraioli P, Riboldi A, Delpiano S, Zanni D, Rizzato G (in press) Bone loss in prednisone-treated sarcoidosis: a follow-up over two years. Ann Ital Med Int

  23. Gluck OS, Murphy WA, Hahn TJ, Hahn B (1981) Bone loss in adults receiving alternate day glucocorticoid therapy. Arthritis Rheum 24:892–898

    Article  PubMed  CAS  Google Scholar 

  24. Baylink DJ (1983) Glucocorticoid-induced osteoporosis. N Engl J Med 309:306–308

    Article  PubMed  CAS  Google Scholar 

  25. Ruegsegger P, Medici TC, Anliker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615–620

    Article  PubMed  CAS  Google Scholar 

  26. Gennari C, Civitelli R (1986) Glucocorticoid-induced osteoporosis. Clin Rheum Dis 12:637–654

    PubMed  CAS  Google Scholar 

  27. Rickers H, Deding A, Christiasen C, Rodbro P, Naestoft J (1982) Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D, calcium phosphate and sodium fluoride administration. Clin Endocrinol 16:409–415

    CAS  Google Scholar 

  28. Collier GH, Cann CE, Pye KH, Riccardi PR, Genant HK (1982) Multivariate analysis of spinal and peripheral mineral loss in patients with rheumatoid arthritis. Arthritis Rheum 25 (suppl):537–545

    Google Scholar 

  29. Locascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, Della Rocca C (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39–51

    Article  PubMed  CAS  Google Scholar 

  30. Montemurro L, Fraioli P, Rizzato G (1991) Bone loss in untreated long-standing sarcoidosis. Sarcoidosis 8:29–34

    PubMed  CAS  Google Scholar 

  31. Spector S, Greenwald M, Silverman SA (1989) Successful treatment of osteoporosis due to steroid-dependent COPD and asthma. Am Rev Resp Dis 139:A16

    Google Scholar 

  32. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM (1982) Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 306:446–450

    Article  PubMed  CAS  Google Scholar 

  33. Ringe JD, Welzel D (1987) Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Clin Pharmacol 33:35–39

    Article  PubMed  CAS  Google Scholar 

  34. Mack TM, Pike MC, Henderson DE (1976) Estrogens and endometrial cancer in a retirement community. N Engl J Med 294:1262–1267

    Article  PubMed  CAS  Google Scholar 

  35. Seeman E, Kumar R, Hunder GC, Scott M, Health H, Riggs BL (1980) Production, degradation and circulating levels of 1–25 dihydroxy vitamin D in health and in chronic glucocorticoid excess. J Clin Invest 66:664–669

    Article  PubMed  CAS  Google Scholar 

  36. Ringe JD, Steinhagen-Thiessen E (1985) Treatment of corticosteroid-induced osteoporosis with salmon calcitonin. In: Masson (ed) 2nd Int Conf on Osteoporosis, pp 371–375

  37. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J (1990) Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. Am Rev Resp Dis 142:104–107

    PubMed  CAS  Google Scholar 

  38. Reid IR, Katz JM, Ibbertson HK, Gray DH (1986) The effects of hydrocortisone, parathyroid hormone, and the biphosphonate. APD, on bone resorption in neonatal mouse calvaria. Calcif Tissue Int 38:38–43

    Article  PubMed  CAS  Google Scholar 

  39. Avioli LV (1987) Calcitonin in post-menopausal and senile osteoporotic syndromes. In: Cohn DV, Martin TJ, Meunier PJ (eds) Calcium regulation and bone metabolism: basic and clinical aspects. Excerpta Medica. Amsterdam, pp 923–931

    Google Scholar 

  40. Reginster JY, Albert A, Lecart MP, Lambelin P, Denis D, Deroisy R, Fontaine MA, Franchimont P (1987) 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481–1483

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sarcoidosis Clinic, Via Giuriati, 17, 20129, Milan, Italy

    Lidia Montemurro, Gianfranco Schiraldi, Patricia Fraioli, Gianpiero Tosi, Angelo Riboldi & Gianfranco Rizzato

  2. Department of Medical Physics, Niguarda Hospital, 20129, Milan, Italy

    Lidia Montemurro, Gianfranco Schiraldi, Patricia Fraioli, Gianpiero Tosi, Angelo Riboldi & Gianfranco Rizzato

Authors
  1. Lidia Montemurro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gianfranco Schiraldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia Fraioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gianpiero Tosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angelo Riboldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gianfranco Rizzato
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montemurro, L., Schiraldi, G., Fraioli, P. et al. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 49, 71–76 (1991). https://doi.org/10.1007/BF02565124

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02565124

Key words

Search

Navigation